Cerebral microvascular nNOS responds to lowered oxygen tension through a bumetanide-sensitive cotransporter and sodium-calcium exchanger

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 5, 2008, Pages

  Bauser Heaton, Holly D ^a   Song, Jin ^a   Bohlen, H Glenn ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Endothelial nitric oxide synthase; Neuronal nitric oxide synthase

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; AMILORIDE; BUMETANIDE; CAVEOLIN 1; CAVTRATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG; 2 (2 (4 (4 NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; DIURETIC AGENT; DRUG DERIVATIVE; ENOS PROTEIN, RAT; INDUCIBLE NITRIC OXIDE SYNTHASE; LOOP DIURETIC AGENT; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT; OXYGEN; PEPTIDE FRAGMENT; SODIUM PROTON EXCHANGE PROTEIN; THIOUREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD VESSEL; BRAIN HYPOXIA; BRAIN OXYGEN TENSION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; MALE; NERVE CELL LESION; NONHUMAN; OXYGEN SENSING; PRIORITY JOURNAL; RAT; VASODILATATION; ANIMAL; ARTERIOLE; BLOOD; BRAIN ARTERY; BRAIN CIRCULATION; BRAIN CORTEX; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; VASCULARIZATION; VASOCONSTRICTION;

AMILORIDE; ANIMALS; ARTERIOLES; BUMETANIDE; CAVEOLIN 1; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DIURETICS; ENZYME ACTIVATION; GLUTAMIC ACID; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM-CALCIUM EXCHANGER; SODIUM-HYDROGEN ANTIPORTER; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; THIOUREA; VASOCONSTRICTION; VASODILATION;

EID: 44949155547     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01074.2007     Document Type: Article

References (48)

1. 2+ exchanger protects C6 glioma cells during chemical hypoxia. Br J Pharmacol 121: 303-309, 1997.
2. Barron LA, Green GM, Khalil RA. Gender differences in vascular smooth muscle reactivity to increases in extracellular sodium salt. Hypertension 39: 425-432, 2002.
3. Bauser-Heaton HD, Bohlen HG. Cerebral microvascular dilation during hypotension and decreased oxygen tension: a role for nNOS. Am J Physiol Heart Circ Physiol 293: H2193-H2201, 2007.
4. Bernatchez PN, Bauer PM, Yu J, Prendergast JS, He P, Sessa WC. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides. Proc Natl Acad Sci USA 102: 761-766, 2005.
5. +-induced intestinal interstitial hyperosmolality and vascular responses during absorptive hyperemia. Am J Physiol Heart Circ Physiol 242: H785-H789, 1982.
6. Bohlen HG. Determinants of resting and passive intestinal vascular pressures in rat and rabbit. Am J Physiol Gastrointest Liver Physiol 253: G587-G595, 1987.
7. Bohlen HG. Enhanced cerebral vascular regulation occurs by age 4 to 5 weeks in spontaneously hypertensive rats. Hypertension 9: 325-331, 1987.
8. Bohlen HG, Harper SL. Evidence of myogenic vascular control in the rat cerebral cortex. Circ Res 55: 554-559, 1984.
9. Bohlen HG, Unthank JL. Rat intestinal lymph osmolarity during glucose and oleic acid absorption. Am J Physiol Gastrointest Liver Physiol 257: G438-G446, 1989.
10. 2+ exchange in hypoxia-related acute astrocyte death. Glia 49: 143-152, 2005.
11. 2+ exchanger gene expression in the ischemic core, periinfarct area, and intact brain regions. J Cereb Blood Flow Metab 26: 502-517, 2005.
12. Buerk DG, Riva CE, Cranstoun SD. Nitric oxide has a vasodilatory role in cat optic nerve head during flicker stimuli. Microvasc Res 52: 13-26, 1996.
13. Chi OZ, Liu X, Weiss HR. Effects of inhibition of neuronal nitric oxide synthase on NMDA-induced changes in cerebral blood flow and oxygen consumption. Exp Brain Res 148: 256-260, 2003.
14. 2+ entry. J Cardiovasc Pharmacol 40: 58-66, 2002.
15. 3-dependent transporters in mouse CNS. J Appl Physiol 95: 292-299, 2003.
16. - cotransporter 1. Am J Physiol Cell Physiol 289: C1492-C1501, 2005.
17. Friedemann MN, Robinson SW, Gerhardt GA. o-Phenylenediamine- modified carbon fiber electrodes for the detection of nitric oxide. Anal Chem 68: 2621-2628, 1996.
18. Garg P, Martin CF, Elms SC, Gordon FJ, Wall SM, Garland CJ, Sutliff RL, O'Neill WC. Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone. Am J Physiol Heart Circ Physiol 292: H2100-H2105, 2007.
19. Gratton JP, Lin MI, Yu J, Weiss ED, Jiang ZL, Fairchild TA, Iwakiri Y, Groszmann R, Claffey KP, Cheng YC, Sessa WC. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 4: 31-39, 2003.
20. Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 6: 408-419, 1984.
21. Harper SL, Bohlen HG, Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol Heart Circ Physiol 246: H17-H24, 1984.
22. Hatakeyama T, Pappas PJ, Hobson RW, Boric MP, Sessa WC, Duran WN. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol 574: 275-281, 2006.
23. + exchanger SM-20220 attenuates ischemic injury in in vitro and in vivo models. Pharmacology 63: 76-81, 2001.
24. Huang H, Martasek P, Roman LJ, Silverman RB. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases. J Med Chem 43: 2938-2945, 2000.
25. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
26. Hudetz AG, Shen H, Kampine JP. Nitric oxide from neuronal NOS plays critical role in cerebral capillary flow response to hypoxia. Am J Physiol Heart Circ Physiol 274: H982-H989, 1998.
27. 2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets 7: 188-198, 2007.
28. 2+ exchanger (NCX) in neurons following ischaemia. J Clin Neurosci 14: 507-514, 2007.
29. - cotransport system in brain capillary endothelial cells: response to endothelin and hypoxia. Neurochem Res 21: 1259-1266, 1996.
30. Kiedrowski L. NCX and NCKX operation in ischemic neurons. Ann NY Acad Sci 1099: 383-395, 2007.
31. 2+ exchange in mitochondrial dysfunction in astrocytes following in vitro ischemia. Am J Physiol Cell Physiol 292: C1113-C1122, 2007.
32. 2+ signaling in astrocytes in an in vitro ischemic model. J Neurosci 24: 9585-9597, 2004.
33. Lindauer U, Kunz A, Schuh-Hofer S, Vogt J, Dreier JP, Dirnagl U. Nitric oxide from perivascular nerves modulates cerebral arterial pH reactivity. Am J Physiol Heart Circ Physiol 281: H1353-H1363, 2001.
34. Loesch A, Burnstock G. Electron-immunocytochemical localization of P2X1 receptors in the rat cerebellum. Cell Tissue Res 294: 253-260, 1998.
35. 2+ exchanger in reperfusion-induced delayed cell death of cultured rat astrocytes. Eur J Neurosci 8: 951-958, 1996.
36. Mungrue IN, Bredt DS. nNOS at a glance: implications for brain and brawn. J Cell Sci 117: 2627-2629, 2004.
37. 2 increases nitric oxide release from endothelial cells. Am J Physiol Heart Circ Physiol 285: H507-H515, 2003.
38. O'Donnell ME, Tran L, Lam TI, Liu XB, Anderson SE. Bumetanide inhibition of the blood-brain barrier Na-K-Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. J Cereb Blood Flow Metab 24: 1046-1056, 2004.
39. 2+ exchange inhibitors. Circ Res 91: 90-92, 2002.
40. Robertson SC, Loftus CM. Effect of N-methyl-D- aspartate and inhibition of neuronal nitric oxide on collateral cerebral blood flow after middle cerebral artery occlusion. Neurosurgery 42: 117-123, 1998.
41. 2 in diabetic rats. Am J Physiol Heart Circ Physiol 249: H540-H546, 1985.
42. Sigma. Product Information. N-[(4S)-4-amino-5-[(2-aminoethyl] (amino] pentyl]-N-nitroguanidine, Tris (online). http://www.sigmaaldrich. com/sigma/product%20information%20sheet/a5727pis.pdf [12 March 2008].
43. Teiwes J, Toto RD. Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. Am J Hypertens 20: 109-117, 2007.
44. Thom SR, Fisher D, Zhang J, Bhopale VM, Ohnishi ST, Kotake Y, Ohnishi T, Buerk DG. Stimulation of perivascular nitric oxide synthesis by oxygen. Am J Physiol Heart Circ Physiol 284: H1230-H1239, 2003.
45. Yoshida T, Limmroth V, Irikura K, Moskowitz MA. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 14: 924-929, 1994.
46. Yousef T, Neubacher U, Eysel UT, Volgushev M. Nitric oxide synthase in rat visual cortex: an immunohistochemical study. Brain Res Brain Res Protoc 13: 57-67, 2004.
47. Zani BG, Bohlen HG. Sodium channels are required during in vivo sodium chloride hyperosmolarity to stimulate increase in intestinal endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 288: H89-H95, 2005.
48. Zani BG, Bohlen HG. Transport of extracellular L-arginine via the cationic amino acid transporter is required during in vivo endothelial nitric oxide production. Am J Physiol Heart Circ Physiol 289: H1381-H1390, 2005.